Last Update 23 Mar 26

Fair value Decreased 8.76%

CVC: Conviction List Status And Buyback Program Will Support Premium Earnings Platform

Analysts have trimmed the price target on CVC Capital Partners to about €17 from roughly €19, citing updated expectations for revenue growth, profit margins, and a lower assumed future P/E multiple.

Analyst Commentary

Recent research shows a mixed but engaged view on CVC Capital Partners, with some analysts still constructive on the equity story while adjusting their numbers to reflect updated assumptions on growth, margins, and valuation multiples.

Bullish Takeaways

Inclusion on the European Conviction List at Goldman Sachs signals that some high profile analysts see CVC as a higher priority idea within their coverage universe, which can support investor attention and liquidity.
Bullish analysts maintain a positive stance despite the lower price targets, indicating that they still see upside potential relative to current trading levels based on their revised models.
Supportive views often rest on execution, with confidence that management can work toward the revenue and profit margin assumptions embedded in current forecasts.
The continued use of a P/E based framework suggests that analysts view CVC as having earnings characteristics that they consider attractive enough to support a premium over some peers.

Bearish Takeaways

Lower price targets, such as the move to about €17.50 from roughly €21.10, point to a more cautious stance on how much investors might be willing to pay for CVC, particularly through a reduced assumed future P/E multiple.
The reset in targets reflects tempered expectations for revenue growth and profit margins, which introduces more execution risk if operating performance does not track current assumptions.
Some bearish analysts may question whether CVC can consistently deliver against these updated growth and profitability forecasts, which can cap how aggressive valuation multiples are in their models.
Target cuts can also signal concern that previous assumptions were too optimistic, prompting investors to focus more closely on quarterly progress against revenue and margin targets.

What's in the News

CVC Capital Partners plc announced a share repurchase program of 10,000,000 shares for €350 million, with an initial €75 million tranche to be executed by J.P. Morgan Securities plc, and plans to cancel repurchased shares by no later than May 12, 2027 (Buyback Transaction Announcements).
The Board of Directors authorized a new buyback plan on March 11, 2026, adding formal board backing to the announced share repurchase activity (Buyback Transaction Announcements).
CVC is among several global private equity firms evaluating a minority stake in Synthimed Labs Pvt. Ltd., as India Resurgence Fund seeks to raise $150 million to $200 million ahead of a potential IPO for the pharmaceutical ingredients maker (M&A Rumors and Discussions).
CVC is also reported to be evaluating the acquisition of EQT Partners' 40% stake in healthtech firm CitiusTech Inc. in a potential deal around $1 billion, alongside other large global investors, with the process described as early stage and managed by J.P. Morgan (M&A Rumors and Discussions).
American International Group, Inc. and CVC announced a partnership that includes up to $1.5 billion from AIG's existing private equity portfolio into CVC's private equity secondaries platform and up to $2 billion of allocations to separately managed accounts and funds across CVC credit strategies, with an initial $1 billion planned through 2026 (Strategic Alliances).

Valuation Changes

Fair Value: revised down from €18.79 to €17.15, a reduction of about 9% in the modelled estimate.
Discount Rate: held broadly flat, moving from 7.24% to 7.24%, indicating only a very small technical adjustment.
Revenue Growth: raised from 9.25% to 12.06%, pointing to a higher projected top line growth rate in the updated assumptions.
Net Profit Margin: nudged up from 57.26% to 58.69%, reflecting slightly stronger expected profitability.
Future P/E: cut from 18.63x to 14.69x, a sizeable step down in the valuation multiple applied to future earnings in the model.

3 views

Key Takeaways

Robust fundraising and strategic expansion into Private Wealth and insurance positions the company for long-term revenue growth and diversified fee income.
Strategic acquisitions and investments in growth areas like AI and infrastructure could enhance revenue, operational efficiency, and margin expansion.
Economic uncertainties, geopolitical risks, longer fundraising timelines, and currency fluctuations pose challenges to CVC Capital Partners' earnings stability and revenue growth.

Catalysts

About CVC Capital Partners

A private equity and venture capital firm specializing in middle market secondaries, infrastructure and credit, management buyouts, leveraged buyouts, growth equity, mature, recapitalizations, strip sales, and spinouts.What are the underlying business or industry changes driving this perspective?

The activation of Europe/Americas Fund IX and Asia VI, as well as strong fundraising efforts, suggest robust fee-generating potential in the near future, expected to boost management fee revenues and predictable earnings.
Strategic expansion into Private Wealth and insurance, with initiatives like CVC-CRED and CVC-PE, highlights a focus on long-term revenue growth and diversification of fee income sources.
Record levels of deployment across private equity and credit sectors, facilitated by the CVC Network's global reach, position the company to capitalize on market opportunities, potentially enhancing revenue and investment returns.
Continued investment in growth areas such as Private Wealth, insurance, and AI could lead to operational efficiencies and new revenue streams, supporting margin expansion over time.
Recent strategic acquisitions and fund launches in infrastructure and secondaries indicate scaling efforts that could lead to significant long-term revenue growth and enhanced EBITDA margins.

CVC Capital Partners Earnings and Revenue Growth

CVC Capital Partners Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming CVC Capital Partners's revenue will grow by 12.1% annually over the next 3 years.
Analysts assume that profit margins will shrink from 63.9% today to 58.7% in 3 years time.
Analysts expect earnings to reach €1.5 billion (and earnings per share of €1.11) by about March 2029, up from €1.2 billion today. The analysts are largely in agreement about this estimate.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 14.7x on those 2029 earnings, up from 9.7x today. This future PE is greater than the current PE for the NL Capital Markets industry at 9.7x.
Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.24%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Economic uncertainty and inconsistent activity levels may impact realizations and consequently affect net margins and earnings stability.
Despite successful fundraising, longer timelines and back-ended processes for future fundraising could pose a risk to predictable revenue streams.
Concentration in Europe, while offering growth potential, also poses geopolitical risks that might affect long-term revenues and earnings stability.
Challenges in exiting investments due to subdued strategic buyer and IPO markets could result in lower near-term profit realizations and affect overall earnings.
Risks associated with currency fluctuations, particularly affecting Asian funds' performance, might challenge the revenue growth and net margins.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of €17.15 for CVC Capital Partners based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €21.0, and the most bearish reporting a price target of just €12.3.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €2.6 billion, earnings will come to €1.5 billion, and it would be trading on a PE ratio of 14.7x, assuming you use a discount rate of 7.2%.
Given the current share price of €10.9, the analyst price target of €17.15 is 36.4% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on CVC Capital Partners?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Stronger Fee Reliability And Execution Will Offset Earnings Margin Pressures Ahead